BuccaGLP

Asset

Oral needle-free sublingual/buccal delivery formulation of GLP-1 receptor agonist

Stage
Stage not known
Modality
Peptide
Target
Insulin/IGF-1 signalling
0
Indications
0
Trials
1
Developer

Indications

0

    In the full profile

    • Targets and what it contains2
    • Owner and partners4
    • Evidence for its targets2
    • Aging relevance1
    • Signals3

    Every asset’s record: target, stage, trials and the evidence behind it.

    See Pro

    Assets